| author name | recommending | commenting | favorite | papers | recom. | cited | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 991 | 0 | 2037 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 4 | [Update] | |
| 0 | 0 | 0 | 22 | 0 | 8 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 33 | 0 | 104 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 1 | [Update] | |
| 0 | 0 | 0 | 10 | 0 | 6 | [Update] | |
| 0 | 0 | 0 | 5 | 0 | 18 | [Update] | |
| 0 | 0 | 0 | 3 | 0 | 1 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 3 | 0 | 11 | [Update] | |
| 0 | 0 | 0 | 5 | 0 | 9 | [Update] | |
| 0 | 0 | 0 | 3 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 24 | 0 | 2 | [Update] | |
| 0 | 0 | 0 | 6 | 0 | 4 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 3 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 14 | 0 | 5 | [Update] | |
| 0 | 0 | 0 | 45 | 0 | 88 | [Update] |
Latest Paper:
Yuka Hama,
Kimiyasu Shiraki,
Yoshihiro Yoshida,
Atsushi Maruyama,
Makoto Yasuda,
Masaaki Tsuda,
Mariko Honda,
Michiaki Takahashi,
Hiroshi Higuchi,
Ichiro Takasaki,
Tohru Daikoku,
Tadaharu Tsumoto
Departments of Virology and Department of Molecular Neurobiology, Graduate School of Medicine and Pharmaceutical Sciences, and Life Science Research Center, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan; Brain Science Institute, Riken, 2-1 Hirosawa, Wako 351-0198, Japan; Department of Dermatology, The Aoto Hospital, Jikei University School of Medicine, 6-41-2 Aoto, Katsushika-ku, Tokyo 125-8506, Japan; Research Foundation for Microbial Diseases of Osaka University, 3-1 Yamada-oka, Suita 565-0871, Japan; Division of Pharmacology, Niigata University, Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan.
Varicella-zoster virus (VZV) expresses immediate early protein (IE) 62, and zoster is associated with neuropathic pain. Brain-derived neurotrophic factor (BDNF) is involved in the neuronal mechanism underlying pain hypersensitivity. Zoster is associated with prodrome and robust booster antibody production to VZV. We hypothesized that intrathecal production of antibody to IE62 cross-reacting with BDNF and the nerve injury by skin lesions may augment allodynia in zoster by enhancing BDNF activity. One of three monoclonal antibodies against the 268-556 peptide of IE62 recognized BDNF. Immunological cross-reactivity between IE62 and BDNF and the effects of anti-IE62 monoclonal antibody (anti-IE62-mAb) cross-reactive with BDNF on BDNF activity in cultured neurons were examined. Anti-IE62-mAb and anti-BDNF-mAb recognized the 414-429 peptide of IE62 and the BDNF dimer. Anti-IE62-mAb significantly augmented BDNF-related transcription in neurons and morphological development of spinal dorsal horn neurons. Serum from patients recognized IE62 and BDNF and enhanced BDNF activity in neurons. The effect of anti-IE62 antibody on mechanical allodynia was characterized by the threshold of allodynia using von Frey filaments in a spinal nerve injury (SNI) in mice. Administration of anti-IE62-mAb to or immunization with cross-reacting IE62 protein to mice significantly enhanced mechanical allodynia on the side with SNI but not on the uninjured side. Anti-IE62 antibody augmented BDNF activity in neurons and allodynia in mice with SNI. Intrathecal production of anti-IE62 antibody augmenting BDNF activity and peripheral nerves injury by zoster may participate in the pathogenesis of allodynia in zoster.
Chapter 3 Construction of Cell-Sized Liposomes Encapsulating Actin and Actin-Cross-linking Proteins.
Kingo Takiguchi,
Ayako Yamada,
Makiko Negishi,
Makoto Honda,
Yohko Tanaka-Takiguchi,
Kenichi Yoshikawa
Division of Biological Science, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Japan.
To shed light on the mechanism underlying the active morphogenesis of living cells in relation to the organization of internal cytoskeletal networks, the development of new methodologies to construct artificial cell models is crucial. Here, we describe the successful construction of cell-sized liposomes entrapping cytoskeletal proteins. We discuss experimental protocols to prepare giant liposomes encapsulating desired amounts of actin and cross-linking proteins including molecular motor proteins, such as fascin, alpha-actinin, filamin, myosin-I isolated from brush border (BBMI), and heavy meromyosin (HMM). Subfragment 1 (S-1) is also studied in comparison to HMM, where S-1 and HMM are single-headed and double-headed derivatives of conventional myosin (myosin-II), respectively. In the absence of cross-linking proteins, actin filaments (F-actin) are distributed homogeneously without any order within the liposomes. In contrast, when actin is encapsulated together with an actin-cross-linking protein, mesh structures emerge that are similar to those in living motile cells. Optical microscopic observations on the active morphological changes of the liposomes are reported.
Yasuhito Tanaka,
Nao Nishida,
Masaya Sugiyama,
Masayuki Kurosaki,
Kentaro Matsuura,
Naoya Sakamoto,
Mina Nakagawa,
Masaaki Korenaga,
Keisuke Hino,
Shuhei Hige,
Yoshito Ito,
Eiji Mita,
Eiji Tanaka,
Satoshi Mochida,
Yoshikazu Murawaki,
Masao Honda,
Akito Sakai,
Yoichi Hiasa,
Shuhei Nishiguchi,
Asako Koike,
Isao Sakaida,
Masatoshi Imamura,
Kiyoaki Ito,
Koji Yano,
Naohiko Masaki,
Fuminaka Sugauchi,
Namiki Izumi,
Katsushi Tokunaga,
Masashi Mizokami
[1] Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.[2] These authors contributed equally to this work.
The recommended treatment for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a genome-wide association study (GWAS) to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population. We found two SNPs near the gene IL28B on chromosome 19 to be strongly associated with NVR (rs12980275, P = 1.93 x 10(-13), and rs8099917, 3.11 x 10(-15)). We replicated these associations in an independent cohort (combined P values, 2.84 x 10(-27)(OR = 17.7; 95% CI = 10. -31.3) and 2.68 x 10(-32)(OR = 27.1; 95% CI = 14.6-50.3), respectively). Compared to NVR, these SNPs were also associated with SVR (rs12980275, P = 3.99 x 10(-24), and rs8099917, P = 1.11 x 10(-27)). In further fine mapping of the region, seven SNPs (rs8105790, rs11881222, rs8103142, rs28416813, rs4803219, rs8099917 and rs7248668) located in the IL28B region showed the most significant associations (P = 5.52 x 10(-28)-2.68 x 10(-32); OR = 22.3-27.1). Real-time quantitative PCR assays in peripheral blood mononuclear cells showed lower IL28B expression levels in individuals carrying the minor alleles (P = .015).
Stem Cell and Drug Discovery Institute, Shimogyo-ku, Kyoto, Japan. wada@scdi.or.jp
BACKGROUND: There are no cures or efficacious treatments for severe motor neuron diseases. It is extremely difficult to obtain naïve spinal motor neurons (sMNs) from human tissues for research due to both technical and ethical reasons. Human embryonic stem cells (hESCs) are alternative sources. Several methods for MN differentiation have been reported. However, efficient production of naïve sMNs and culture cost were not taken into consideration in most of the methods. METHODS/PRINCIPAL FINDINGS: We aimed to establish protocols for efficient production and enrichment of sMNs derived from pluripotent stem cells. Nestin+ neural stem cell (NSC) clusters were induced by Noggin or a small molecule inhibitor of BMP signaling. After dissociation of NSC clusters, neurospheres were formed in a floating culture containing FGF2. The number of NSCs in neurospheres could be expanded more than 30-fold via several passages. More than 33% of HB9+ sMN progenitor cells were observed after differentiation of dissociated neurospheres by all-trans retinoic acid (ATRA) and a Shh agonist for another week on monolayer culture. HB9+ sMN progenitor cells were enriched by gradient centrifugation up to 80% purity. These HB9+ cells differentiated into electrophysiologically functional cells and formed synapses with myotubes during a few weeks after ATRA/SAG treatment. CONCLUSIONS AND SIGNIFICANCE: The series of procedures we established here, namely neural induction, NSC expansion, sMN differentiation and sMN purification, can provide large quantities of naïve sMNs derived from human and monkey pluripotent stem cells. Using small molecule reagents, reduction of culture cost could be achieved.
Sleep Disorders Research Project, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan. honda@prit.go.jp
OBJECTIVES: The cause of hypocretin cell loss in human narcolepsy-cataplexy is unknown but has been suggested to be neurodegenerative in nature. To test this hypothesis, we evaluated the remaining hypocretin cells in human narcolepsy brains for the presence of aggregated protein inclusions, gliosis, and inflammation. METHODS: Brains were examined by routine histologic methods for potential comorbid neurodegenerative diseases and through immunohistochemical screening for protein inclusions in the hypothalamus. Hypothalamic sections of 4 subjects with narcolepsy and 5 nonneurologic controls were examined immunohistochemically with antibodies against ubiquitin (a marker of aggregated protein), allograft inflammatory factor 1 (AIF1, a microglial activation marker), glial fibrillary acidic protein (GFAP, a reactive astrocytic marker), and hypocretin. Hypothalami of subjects with narcolepsy were additionally examined for the presence of known components of protein aggregates (tau, alpha-synuclein, amyloid beta, and TDP-43). RESULTS: Hypocretin cells were markedly decreased in all 4 subjects with narcolepsy. Ubiquitinated inclusions were not observed in the total of 96 remaining hypocretin cells in these subjects. Further, we noted that even in patients with dementia neuropathology, the lateral hypothalamic hypocretin area was spared from ubiquitinated inclusions. AIF1 and GFAP staining in the perifornical area was unremarkable. CONCLUSIONS: Our findings suggest that hypocretin cell loss does not involve ubiquitinated inclusions, the hallmark of most neurodegenerative diseases. The lack of increased markers of inflammation also argues against a progressive and continuous neurodegenerative process.
Ikuo Ishige,
Tokiko Nagamura-Inoue,
Masaki Honda,
Ratanakanit Harnprasopwat,
Michiko Kido,
Mitsuhiro Sugimoto,
Hiromitsu Nakauchi,
Arinobu Tojo
Department of Cell Processing and Transfusion, Institute of Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo, 108-8639, Japan.
We isolated mesenchymal stem cells (MSC) from arteries (UCA), veins (UCV), and Wharton's jelly (UCWJ) of human umbilical cords (UC) and determined their relative capacities for sustained proliferation and multilineage differentiation. Individual UC components were dissected, diced into 1-2 mm(3) fragments, and aligned in explant cultures from which migrating cells were isolated using trypsinization. Preparations from 13 UCs produced 13 UCWJ, 11 UCV, and 10 UCA cultures of fibroblast-like, spindle-shaped cells negative for CD31, CD34, CD45, CD271, and HLA-class II, but positive for CD13, CD29, CD44, CD73, CD90, CD105, and HLA-class I. UCV cells exhibited a significantly higher frequency of colony-forming units fibroblasts than did UCWJ and UCA cells. Individual MSCs could be selectively differentiated into osteoblasts, chondrocytes, and adipocytes. When compared for osteogenic potential, UCWJ cells were the least effective precursors, whereas UCA-derived cells developed alkaline phosphatase activity with or without an osteogenic stimulus. UC components, especially blood vessels, could provide a promising source of MSCs with important clinical applications.
Department of Physiology, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; Laboratory of Cerebral Integration, National Institutes for Physiological Sciences, 38 Nishigonaka, Myodaiji-cho, Okazaki 444-8585, Japan; Graduate School of Informatics, Kyoto University, Kyoto, Gokasho, Uji, Kyoto 611-0011, Japan; Japan Science and Technology Corporation (JST), SORST, 4-1-8 Honmachi, Kawaguchi, Saitama 331-0012, Japan.
Human neuro-imaging studies have often reported co-activation of the dorsal premotor cortex (PMd) and the posterior parietal cortex (PPC) during internal operation of visuospatial information, referred to here as "visuospatial mental operation". However, the functions assigned to the PMd and PPC during these tasks are still unclear. Here, we examined the significance of these two areas for a visuospatial mental operation using the transcranial magnetic stimulation (TMS) technique. Subjects performed a task in which a visuospatial mental operation was required. A localization study conducted prior to the TMS experiment using functional magnetic resonance imaging (fMRI) revealed that the PMd and the medial part of the PPC, precuneus (PCu), were specifically activated during the visuospatial mental operation. Then, we impeded the activities of the PMd and the PCu in the right hemisphere during the same task using double-pulse TMS to determine whether these activities were necessary for the task. The TMS was applied at different times in relation to the visuospatial mental operation cue. Consequently, only the TMS applied at 300 ms after the cue affected the task performance. Furthermore, we found that the TMS at this time to each area differentially affected the performance: TMS to the PMd hindered the performance of the task whereas TMS to the PCu facilitated it without a speed/accuracy trade-off. These effects were not found in the control condition that lacked a visuospatial mental operation. These findings suggest that the PMd and the PCu are involved in differential aspects of visuospatial mental operations.
Azusa Kitao,
Yasunori Sato,
Seiko Kitamura,
Kenichi Harada,
Motoko Sasaki,
Hiroyasu Morikawa,
Susumu Shiomi,
Masao Honda,
Osamu Matsui,
Yasuni Nakanuma
From the Departments of Human Pathology, Radiology, and Gastroenterology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan; and the Departments of Hepatology, and Nuclear Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Idiopathic portal hypertension (IPH) represents noncirrhotic portal hypertension of unknown etiology, mainly due to stenosis of peripheral portal veins. This study was performed to clarify the mechanism of portal venous stenosis in IPH from the viewpoint of the contribution of the endothelial to mesenchymal transition of the portal vein endothelium via transforming growth factor-beta1 (TGF-beta1)/Smad activation. In vitro experiments using human dermal microvascular endothelial cells demonstrated that TGF-beta1 induced myofibroblastic features in human dermal microvascular endothelial cells, including spindle cell morphology, reduction of CD34 expression, and induction of S100A4, alpha-smooth muscle actin, and COL1A1 expression, as well as the increased nuclear expression of phospho-Smad2. Bone morphogenic protein-7 preserved the endothelial phenotype of human dermal microvascular endothelial cells. Immunohistochemical analysis showed that endothelial cells of the peripheral portal veins in IPH were characterized by the decreased expression of CD34 and the enhanced nuclear expression of phospho-Smad2; these results also confirmed the expression of S100A4 and COL1A1 in the portal vein endothelium. Serum TGF-beta1 levels in patients with IPH were significantly higher than those of healthy volunteers and patients with chronic viral hepatitis/liver cirrhosis, while an elevation of serum bone morphogenic protein-7 levels was not observed. These results suggest that the endothelial to mesenchymal transition of the portal venous endothelium via TGF-beta1/Smad activation is associated with portal venous stenosis in IPH, and bone morphogenic protein-7 may therefore be a suitable therapeutic candidate for IPH.
Hitomi Ichinose,
Zui Fujimoto,
Mariko Honda,
Koichi Harazono,
Yukifumi Nishimoto,
Atsuko Uzura,
Satoshi Kaneko
National Food Research Institute, Japan;
Arabinogalactan proteins (AGPs) are a family of plant cell surface proteoglycans and considered to involve in plant growth and development. Because AGPs are very complex molecule, glycoside hydrolases capable of degrading AGPs are powerful tools for analyses of the AGPs. We previously reported such enzymes from Streptomyces avermitilis. Recently, a beta-L-arabinopyranosidase was purified from the culture supernatant of the bacterium, and its corresponding gene was identified. The primary structure of the protein revealed that the catalytic module was highly similar to that of glycoside hydrolase family 27 (GH27) alpha-D-galactosidases. The recombinant protein was successfully expressed as a secreted 64-kDa protein using a Streptomyces expression system. The specific activity toward p-nitrophenyl-beta-L-arabinopyranoside was 18 mumol p-nitrophenol/min/mg, which was 67 times higher than that toward p-nitrophenyl-alpha-D-galactopyranoside. The enzyme could remove .1% and 45% L-arabinose from gum arabic or larch arabinogalactan, respectively. X-ray crystallographic analysis reveals that the protein had a GH27 catalytic domain, an antiparallel beta-domain containing Greek key motifs, another antiparallel beta-domain forming a jellyroll structure, and a carbohydrate-binding module family 13 domain. Comparison of the structure of this protein with that of alpha-D-galactosidase showed a single amino acid substitution (aspartic acid to glutamic acid) in the catalytic pocket of beta-L-arabinopyranosidase, and a space for the hydroxymethyl group on the C-5 carbon of D-galactose bound to alpha-galactosidase was changed in beta-L-arabinopyranosidase. Mutagenesis study revealed that the residue is critical for modulating the enzyme activity. This is the first report in which beta-L-arabinopyranosidase is classified as a new member of the GH27 family.
Ryoji Mizuno,
Hitomi Ichinose,
Mariko Honda,
Koji Takabatake,
Itaru Sotome,
Tomoyuki Takai,
Tomoko Maehara,
Hiroshi Okadome,
Seiichiro Isobe,
Mitsuru Gau,
Satoshi Kaneko
Food Biotechnology Division, National Food Research Institute.
The possibility of using two kinds of sorghum as raw materials in consolidated bioprocessing bioethanol production using Flammulina velutipes was investigated. Enzymatic saccharification of sweet sorghum was not as high as in brown mid-rib (bmr) mutated sorghum, but the amount of ethanol production was higher. Ethanol production from bmr mutated sorghum significantly increased when saccharification enzymes were added to the culture.
